Microneedle patch to help peanut allergy safety in kids
Official title: Scale-up manufacturing of microneedle stamp for peanut allergen immunotherapy
Funded at Moonlight Therapeutics, INC. · NIH-11326335 · Data updated 2026-11-12
A pediatric-friendly approach aims to deliver peanut allergy treatment using tiny skin patches to reduce the risk of severe reactions after accidental peanut exposure.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Moonlight Therapeutics, INC. NIH-funded |
| Lab location | 1 site (Marietta, UNITED STATES) |
| Project start | May 6, 2024 |
| Project end | April 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $999,380 |
| NIH project number | 5SB1AI184000-03 |
| Project ID | NIH-11326335 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children 0–11 years old with peanut allergy or a high risk of peanut-related reactions.
✕Less likely to help
Children without peanut allergy or those unable to tolerate the microneedle approach may not benefit.
What this research studies
This project focuses on scaling up a microneedle stamp that delivers peanut allergens through the skin to desensitize children aged 0–11. It emphasizes manufacturing steps to ensure consistent dosing, safety, and practicality for clinical use. If successful, the approach could provide a convenient, quick therapy that fits into everyday life for families dealing with food allergies.
Why it matters
Potential benefit: If successful, this microneedle therapy could lower the chance of severe allergic reactions and improve quality of life for children with peanut allergy.
How similar studies have gone: There is ongoing research in immunotherapy for food allergies, with some therapies showing promise in desensitization approaches; this work adds a novel delivery method.
Where this research is happening
-
Moonlight Therapeutics, INC.
Marietta, United States Active
Researchers
- Principal investigator: Patel, Samirkumar — Moonlight Therapeutics, INC.
- Study coordinator: Patel, Samirkumar
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
A center focused on immunotherapy for pediatric cancers.
This study is exploring new ways to use the body's immune system to fight childhood cancers, aiming to create better treatments for kids whose cancers haven't responded well to standard therapies.
-
Algorithms to find HLA-E neoantigens for cancer immunotherapy
Aims to develop computer methods to discover tumor-specific targets presented by HLA-E to guide new T cell therapies for cancer.
-
Immunotherapy for glioblastoma: advancing treatment and understanding
A patient-friendly summary of a grant exploring new immune-based treatments for glioblastoma to improve options for people affected by this brain cancer.
-
How CRISPR-based gene activation could shape immunotherapy responses in clear cell cancers
A research project at Stanford is using CRISPR-based gene activation to understand why some clear cell ovarian and kidney cancers respond to immunotherapy while others do not.
-
Hybrid biomaterial system to boost immunotherapy for rheumatoid arthritis
A new, patient-facing immunotherapy approach uses specialized particles to retrain the immune system to calm RA in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.